MD Medical Group's revenue for 2025 increased by 31.2% and amounted to 43.455 billion rubles. compared to a year earlier. This is stated in the company's message.
Comparable revenue (LFL) increased by 15.6% to RUB 38.281 billion.
Revenue of Moscow hospitals increased by 17.1% to 19.081 billion rubles due to the growth of revenue in the field of childbirth, outpatient referral and inpatient treatment;
Revenue of regional hospitals increased by 30.2% to RUB 11.586 billion. due to increased revenue from outpatient visits, inpatient treatment, and childbirth.
Revenue of outpatient clinics in Moscow and the Moscow Region increased by 26.5% to RUB 4.039 billion due to increased revenue from outpatient visits, largely due to the results of new clinics opened in 2024-2025, as well as high demand for IVF procedures.
Revenue of outpatient clinics in the regions increased by 84.6% to 8.623 billion rubles, mainly due to the results of new clinics opened and acquired in 2024-2025, which had a positive impact on both the dynamics of visits and IVF procedures.
The total amount of capital expenditures for 2025 amounted to 4.266 billion rubles.
The number of outpatient visits increased by 76.2% to 4.3 million, while the average receipt increased by 13.2% to 7 thousand rubles in Moscow and 7.3% to 2.7 thousand rubles in the regions.
On December 29, 2025, MD Medical Group closed a deal to acquire an eight-story building with an area of 17,954 thousand square meters, located in the Northeastern Administrative District of Moscow at 15 Zubarev Lane, building 1. The total amount of the transaction will amount to 2.4 billion rubles.
MD Medical Group operates in the Russian market of private medical services.
Today, the company unites 88 medical institutions, including 14 multidisciplinary hospitals and 74 outpatient clinics with a presence in 35 regions of the Russian Federation.
The authorized capital of the company is 75.125 million ordinary shares with a nominal value of 7.169 rubles.
MD Medical Group's net profit under IFRS for the first half of 2025 increased by 3.6% to 5.064 billion rubles. compared to a year earlier. Revenue increased by 22.2% to RUB 19.264 billion, and EBITDA increased by 15.1% to RUB 5.823 billion.
